Suppr超能文献

开发并验证一种预测模型以辅助管理未破裂的腹主动脉瘤。

Development and Validation of a Predictive Model to Aid in the Management of Intact Abdominal Aortic Aneurysms.

机构信息

Department of Surgery, University of Otago, Christchurch, New Zealand.

Department of Public Health, University of Otago, Wellington, New Zealand.

出版信息

Eur J Vasc Endovasc Surg. 2018 Jul;56(1):48-56. doi: 10.1016/j.ejvs.2018.03.013. Epub 2018 Apr 9.

Abstract

OBJECTIVE/BACKGROUND: Predicting outcomes prior to elective abdominal aortic aneurysm repair (AAA) requires critical decision making, as the treatment offered is a prophylactic procedure to prevent death from a ruptured AAA. The aim of this work was to develop and validate a model that may predict outcomes for patients with an AAA and hence aid in clinical decision making.

METHODS

A discrete event simulation model was built to simulate the natural history of a patient with an AAA and to predict the 30 day and 2-5 year survival of patients undergoing treatment and surveillance. The input parameters of AAA behavior and impact of comorbidities on survival were derived from the published literature and the New Zealand national life tables. The model was externally validated using a cohort of patients that underwent AAA repair (n = 320) and a cohort of patients undergoing small AAA surveillance (n = 376). All patients had completed at least 5 years of follow up.

RESULTS

The model was run three times for each data set to test. This produced a SD < 1%, indicating excellent reproducibility. The observed 30 day mortality for the patients undergoing AAA repair was 9/320 (2.8%) and the expected (model predicted) mortality was 3.8% (c-statistic 0.87 [95 confidence interval 0.75-1.0]). The c-statistic for the predicted 2-5 year survival ranged from 0.68 to 0.71 for the repaired AAA cohort and 0.69 to 0.73 for patients with a small AAA on surveillance.

CONCLUSION

The AAA clinical decision tool has the ability to accurately predict the 5 year survival of patients with an AAA. This tool can be used during clinical decision making to better inform clinicians and patients of long-term outcomes. Further validation studies in a wider AAA population are required to test the broader clinical utility of this AAA clinical decision tool.

摘要

目的/背景:在择期进行腹主动脉瘤修复(AAA)之前预测结果需要做出关键决策,因为所提供的治疗是一种预防破裂性 AAA 导致死亡的预防性手术。本研究旨在开发和验证一种模型,该模型可以预测 AAA 患者的结果,从而有助于临床决策。

方法

构建了一个离散事件仿真模型来模拟 AAA 患者的自然病史,并预测接受治疗和监测的患者的 30 天和 2-5 年生存率。AAA 行为的输入参数和合并症对生存率的影响来自已发表的文献和新西兰国家生命表。使用接受 AAA 修复的患者队列(n=320)和接受小 AAA 监测的患者队列(n=376)对模型进行外部验证。所有患者均完成了至少 5 年的随访。

结果

该模型对每个数据集进行了三次测试运行。结果显示 SD<1%,表明具有极好的可重复性。接受 AAA 修复的患者的 30 天死亡率为 9/320(2.8%),而预期(模型预测)死亡率为 3.8%(C 统计量 0.87[95%置信区间 0.75-1.0])。对于接受 AAA 修复的患者,预测的 2-5 年生存率的 C 统计量范围为 0.68 至 0.71,对于接受小 AAA 监测的患者,C 统计量范围为 0.69 至 0.73。

结论

AAA 临床决策工具能够准确预测 AAA 患者的 5 年生存率。该工具可用于临床决策,以更好地向临床医生和患者告知长期结果。需要在更广泛的 AAA 人群中进行进一步的验证研究,以测试该 AAA 临床决策工具的更广泛临床实用性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验